Literature DB >> 21880847

Hepatic iron stores are increased as assessed by magnetic resonance imaging in a Chinese population with altered glucose homeostasis.

Xuan Zheng1, Tao Jiang, Hong Wu, Dezeng Zhu, Ling Wang, Rui Qi, Min Li, Changquan Ling.   

Abstract

BACKGROUND: Emerging scientific evidence has disclosed a correlation between iron metabolism and type 2 diabetes (T2D).
OBJECTIVE: The objective of this study was to test the hypothesis that body iron stores are higher in a Chinese population with altered glucose homeostasis.
DESIGN: Serum iron, ferritin, and soluble transferrin receptor concentrations were measured in 298 subjects, including 70 subjects with normal glucose tolerance (NGT group), 60 subjects with prediabetes (prediabetes group), and 168 subjects with T2D (T2D group). Hepatic iron stores in 88 subjects were assessed by using a magnetic resonance imaging (MRI) T2* gradient-recalled-echo technique. A general linear model ANOVA was performed for comparisons between groups after adjustment for age and BMI. Stepwise multiple linear regression analysis was used to identify factors associated with the MRI-estimated hepatic iron concentration (M-HIC).
RESULTS: Mean (±SD) M-HIC and R2* values in the prediabetes and T2D groups were significantly higher than in the NGT group (M-HIC: 40.6 ± 8.6 and 39.3 ± 10.7 μmol/g compared with 27.8 ± 9.1 μmol/g; R2* values: 47.9 ± 11.9 and 47.3 ± 11.5 s(-1) compared with 34.9 ± 7.0 s(-1); all P < 0.01). No significant difference was shown in M-HIC and R2* values between prediabetes and T2D groups. The M-HIC independently contributed to 43.3% of the glycated hemoglobin variance after adjustment for main clinical indexes (P < 0.001). The proportions of subjects with mild hepatic iron overload in the NGT, prediabetes, and T2D groups were 12.5%, 70.6%, and 63.6%, respectively.
CONCLUSIONS: To our knowledge, our findings provide novel evidence to support the hypothesis of a mild iron overload in patients with prediabetes and T2D. A cohort study concerned with the effect of the attenuation of excess iron on glucose metabolism in a prediabetic population is warranted.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21880847     DOI: 10.3945/ajcn.111.015743

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  8 in total

Review 1.  Diagnostic and therapeutic implications of the association between ferritin level and severity of nonalcoholic fatty liver disease.

Authors:  Luca Valenti; Paola Dongiovanni; Silvia Fargion
Journal:  World J Gastroenterol       Date:  2012-08-07       Impact factor: 5.742

2.  Sphingosine-1-phosphate transporter spinster homolog 2 is essential for iron-regulated metastasis of hepatocellular carcinoma.

Authors:  Min Li; Yuxiao Tang; Dongyao Wang; Xiaofeng Zhai; Hui Shen; Chen Zhong; Man Yao; Aiguo Jin; Zhengjun Zhou; Shaolai Zhou; Jia Fan; Chang-Quan Ling; Chen Ling
Journal:  Mol Ther       Date:  2021-09-20       Impact factor: 11.454

3.  Body weight and its influence on hepcidin levels in patients with type 2 diabetes: A systematic review and meta-analysis of clinical studies.

Authors:  Fransina Ndevahoma; Munyaradzi Mukesi; Phiwayinkosi V Dludla; Bongani B Nkambule; Elina P Nepolo; Tawanda M Nyambuya
Journal:  Heliyon       Date:  2021-03-11

4.  The A736V TMPRSS6 polymorphism influences hepatic iron overload in nonalcoholic fatty liver disease.

Authors:  Luca Valenti; Raffaela Rametta; Paola Dongiovanni; Benedetta M Motta; Elena Canavesi; Serena Pelusi; Edoardo A Pulixi; Anna L Fracanzani; Silvia Fargion
Journal:  PLoS One       Date:  2012-11-05       Impact factor: 3.240

5.  Hyperglycemia promotes microvillus membrane expression of DMT1 in intestinal epithelial cells in a PKCα-dependent manner.

Authors:  Luqing Zhao; Thomas Bartnikas; Xiangpeng Chu; Janet Klein; Chris Yun; Shanthi Srinivasan; Peijian He
Journal:  FASEB J       Date:  2018-11-13       Impact factor: 5.834

6.  Measurement of liver iron by magnetic resonance imaging in the UK Biobank population.

Authors:  Andy McKay; Henry R Wilman; Andrea Dennis; Matt Kelly; Michael L Gyngell; Stefan Neubauer; Jimmy D Bell; Rajarshi Banerjee; E Louise Thomas
Journal:  PLoS One       Date:  2018-12-21       Impact factor: 3.240

7.  Renal iron overload in rats with diabetic nephropathy.

Authors:  Jesus H Dominguez; Yunlong Liu; Katherine J Kelly
Journal:  Physiol Rep       Date:  2015-12-22

8.  Serum ferritin as a risk factor for type 2 diabetes mellitus, regulated by liver transferrin receptor 2.

Authors:  Rui Zhang; Xinmei Huang; Yue Li; Zhiyan Yu; Yueyue Wu; Bingbing Zha; Heyuan Ding; Shufei Zang; Jun Liu
Journal:  Endocr Connect       Date:  2021-11-25       Impact factor: 3.335

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.